Urinary incontinence
Conditions
Interventions
This is an observational study in which no intervention will be performed within the scope of the protocol, with the objective of evaluating outcomes in patients previously treated with intravesical a
the estimated number of participants is 300 patients, with a follow-up period between the years 2024 and 2026, and the reference period of the study includes patients who underwent bladder augmentatio
Sponsors
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients followed at the Voiding Dysfunction and Neuro-urology outpatient clinic; treated with intravesical application of botulinum toxin and or bladder augmentation for neurogenic detrusor overactivity; between 1990 and the present; who agree to participate; who consent to complete the study questionnaires
Exclusion criteria
Exclusion criteria: Patients who refuse or are unable to participate or complete the questionnaires; patients who received botulinum toxin or underwent bladder augmentation for non-neurogenic causes; patients who were treated with therapeutic modalities that are not part of the objectives of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to evaluate the variation in clinical outcomes related to neurogenic detrusor overactivity after the proposed intervention, verified through the application of standardized quality-of-life and urinary continence questionnaires, by observing differences in the scores obtained between the pre-intervention and post-intervention assessments. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected | — |
Countries
Brazil
Contacts
Public ContactVicktor Pinto
Hospital das Clinicas da Universidade de Sao Paulo
Outcome results
None listed